{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:15:38Z","timestamp":1783116938833,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02901-9","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T14:02:15Z","timestamp":1716559335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elucidating the role of T-Reg related cytokines: serum transforming growth factor beta and interleukin-35 in alopecia areata"],"prefix":"10.1007","volume":"316","author":[{"given":"Tugcan","family":"Yuksek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzeyyen","family":"Gonul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda Pelin","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Bengu","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra Isikoglu","family":"Hatil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"crossref","unstructured":"Bertolini M, McElwee K, Gilhar A, Bulfone-Paus S, Paus R (2020) Hair follicle immune privilege and its collapse in alopecia areata. Exp Dermatol 29(8):703\u2013725","DOI":"10.1111\/exd.14155"},{"issue":"3","key":"2901_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2133.2006.07377.x","volume":"155","author":"P Freyschmidt-Paul","year":"2006","unstructured":"Freyschmidt-Paul P, McElwee KJ, Hoffmann R, Sundberg JP, Vitacolonna M, Kissling S et al (2006) Interferon-\u03b3-deficient mice are resistant to the development of Alopecia Areata. Br J Dermatol 155(3):515\u2013521","journal-title":"Br J Dermatol"},{"issue":"1","key":"2901_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jocd.12970","volume":"19","author":"RK Gautam","year":"2020","unstructured":"Gautam RK, Singh Y, Gupta A, Arora P, Khurana A, Chitkara A (2020) The profile of cytokines (IL-2, IFN-\u03b3, IL-4, IL-10, IL-17A, and IL-23) in active Alopecia Areata. J Cosmet Dermatol 19(1):234\u2013240","journal-title":"J Cosmet Dermatol"},{"key":"2901_CR4","doi-asserted-by":"crossref","unstructured":"Lee GR (2018) The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci. ;19(3)","DOI":"10.3390\/ijms19030730"},{"issue":"10","key":"2901_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/1346-8138.12978","volume":"42","author":"YM Han","year":"2015","unstructured":"Han YM, Sheng YY, Xu F, Qi SS, Liu XJ, Hu RM et al (2015) Imbalance of T-helper 17 and regulatory T cells in patients with Alopecia Areata. J Dermatol 42(10):981\u2013988","journal-title":"J Dermatol"},{"key":"2901_CR6","unstructured":"Speiser JJ, Mondo D, Mehta V, Marcial SA, Kini A, Hutchens KA et al Regulatory T-cells in Alopecia Areata"},{"issue":"3","key":"2901_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/bjd.12396","volume":"169","author":"MK Tembhre","year":"2013","unstructured":"Tembhre MK, Sharma VK (2013) T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active Alopecia Areata. Br J Dermatol 169(3):543\u2013548","journal-title":"Br J Dermatol"},{"issue":"0","key":"2901_CR8","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/bmfj.2020.28466.1250","volume":"0","author":"A El-Refaey","year":"2021","unstructured":"El-Refaey A, El-Habak D, Khashaba R, Fawzy R (2021) Serum levels of transforming growth factor Beta1 (TGF \u03b21) in patients with Alopecia Areata. Benha Med J 0(0):0\u20130","journal-title":"Benha Med J"},{"issue":"6","key":"2901_CR9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.5114\/ada.2021.112278","volume":"38","author":"M Wojciechowska-Zdrojowy","year":"2021","unstructured":"Wojciechowska-Zdrojowy M, Jankowska-Konsur A, Nowicka-Suszko D, Szepietowski JC, Hryncewicz-Gw\u00f3\u017ad\u017a A (2021) Comparison of serum concentrations of interleukins 10, 12, 17 and 35 between patients with alopecia areata and controls. Postep Dermatologii i Alergol 38(6):1052\u20131057","journal-title":"Postep Dermatologii i Alergol"},{"issue":"8","key":"2901_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1468-3083.2008.02699.x","volume":"22","author":"A Kavak","year":"2008","unstructured":"Kavak A, Ye\u015fildal N, Parlak AH, G\u00f6kdemir G, Aydo\u011fan I, Anul H et al (2008) Alopecia Areata in Turkey: demographic and clinical features. J Eur Acad Dermatol Venereol 22(8):977\u2013981","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2901_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.autrev.2005.03.006","volume":"4","author":"CA Aoki","year":"2005","unstructured":"Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA et al (2005) Transforming growth factor \u03b2 (TGF-\u03b2) and autoimmunity. Autoimmun Rev 4(7):450\u2013459","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2901_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1684\/ecn.2013.0331","volume":"24","author":"I Manolova","year":"2013","unstructured":"Manolova I, Gerenova J, Ivanova M (2013) Serum levels of transforming growth factor-\u03b21 (TGF-\u03b21) in patients with systemic lupus erythematosus and Hashimoto\u2019s thyroiditis. Eur Cytokine Netw 24(1):69\u201374","journal-title":"Eur Cytokine Netw"},{"issue":"9","key":"2901_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00403-011-1154-8","volume":"303","author":"CX Tu","year":"2011","unstructured":"Tu CX, Jin WW, Lin M, Wang ZH, Man MQ (2011) Levels of TGF-\u03b2 1 in serum and culture supernatants of CD4\u2009+\u2009CD25\u2009+\u2009T cells from patients with non-segmental vitiligo. Arch Dermatol Res 303(9):685\u2013689","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"2901_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/pcmr.12355","volume":"28","author":"L Zhou","year":"2015","unstructured":"Zhou L, Shi Y-L, Li K, Hamzavi I, Gao T-W, Huggins RH et al (2015) Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development. Pigment Cell Melanoma Res 28(3):324\u2013329","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"2901_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1087-0024.2003.00807.x","volume":"8","author":"R Paus","year":"2003","unstructured":"Paus R, Ito N, Takigawa M, Ito T (2003) The hair follicle and immune privilege. J Investig Dermatology Symp Proc 8(2):188\u2013194","journal-title":"J Investig Dermatology Symp Proc"},{"issue":"6","key":"2901_CR16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/jdv.14775","volume":"32","author":"S-H Loh","year":"2018","unstructured":"Loh S-H, Moon H-N, Lew B-L, Sim W-Y (2018) Role of T helper 17 cells and T regulatory cells in Alopecia Areata: comparison of lesion and serum cytokine between controls and patients. J Eur Acad Dermatol Venereol 32(6):1028\u20131033","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2901_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/09546634.2020.1752887","volume":"33","author":"RP Manimaran","year":"2022","unstructured":"Manimaran RP, Ramassamy S, Rajappa M, Chandrashekar L (2022) Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in Alopecia Areata. J Dermatolog Treat 33(1):324\u2013328","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"2901_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","volume":"4","author":"Q Lan","year":"2012","unstructured":"Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z, Zheng SG (2012) Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 4(1):22\u201328","journal-title":"J Mol Cell Biol"},{"issue":"NOV","key":"2901_CR19","first-page":"1","volume":"7","author":"H Hasegawa","year":"2016","unstructured":"Hasegawa H, Mizoguchi I, Chiba Y, Ohashi M, Xu M, Yoshimoto T (2016) Expanding diversity in molecular structures and functions of the IL-6\/IL-12 heterodimeric cytokine family. Front Immunol 7(NOV):1\u201310","journal-title":"Front Immunol"},{"key":"2901_CR20","doi-asserted-by":"publisher","unstructured":"Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J et al (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol [Internet]. ;11(12):1093\u2013101. https:\/\/doi.org\/10.1038\/ni.1952","DOI":"10.1038\/ni.1952"},{"issue":"3","key":"2901_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12016-015-8468-9","volume":"49","author":"J Choi","year":"2015","unstructured":"Choi J, Leung PSC, Bowlus C, Gershwin ME (2015) IL-35 and autoimmunity: a comprehensive perspective. Clin Rev Allergy Immunol 49(3):327\u2013332","journal-title":"Clin Rev Allergy Immunol"},{"key":"2901_CR22","doi-asserted-by":"publisher","unstructured":"Guan SY, Leng RX, Khan MI, Qureshi H, Li XP, Ye DQ et al (2017) Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases. Inflammation [Internet]. ;40(1):303\u201310. https:\/\/doi.org\/10.1007\/s10753-016-0453-9","DOI":"10.1007\/s10753-016-0453-9"},{"issue":"6","key":"2901_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"R-X Wang","year":"2014","unstructured":"Wang R-X, Yu C-R, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV et al (2014) Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 20(6):633\u2013641","journal-title":"Nat Med"},{"issue":"1","key":"2901_CR24","first-page":"11","volume":"2","author":"R Shams","year":"2017","unstructured":"Shams R, Ali EM (2017) IL-35- and IL-10-Dependent immunoregulatory lymphocytes in rheumatoid arthritis. Sci J Immunol Immunother [Internet] 2(1):11\u2013017 Available from: www.scireslit.com","journal-title":"Sci J Immunol Immunother [Internet]"},{"issue":"8","key":"2901_CR25","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2337\/dc16-2121","volume":"40","author":"D Espes","year":"2017","unstructured":"Espes D, Singh K, Sandler S, Carlsson P-O (2017) Increased Interleukin-35 levels in patients with type 1 diabetes with remaining C-Peptide. Diabetes Care 40(8):1090\u20131095","journal-title":"Diabetes Care"},{"issue":"5","key":"2901_CR26","first-page":"521","volume":"64","author":"M-H Saeed","year":"2021","unstructured":"Saeed M-H, Kurosh K, Zahra A, Hossein DM, Davood R, Ataollahi MR (2021) Decreased serum levels of IL-27and IL-35 in patients with Graves disease. Arch Endocrinol Metab 64(5):521\u2013527","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"2901_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5603\/EP.a2019.0018","volume":"70","author":"M Shuai","year":"2019","unstructured":"Shuai M, Ni Y, Jian X, He S, Zhang J-A (2019) The level of IL-35 in the circulation of patients with Graves\u2019 disease. Endokrynol Pol 70(4):318\u2013322","journal-title":"Endokrynol Pol"},{"key":"2901_CR28","doi-asserted-by":"publisher","unstructured":"Fonseca-Camarillo G, Furuzawa-Carballeda J, Yamamoto-Furusho JK (2015) Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease. Cytokine [Internet]. ;75(2):389\u2013402. https:\/\/doi.org\/10.1016\/j.cyto.2015.04.009","DOI":"10.1016\/j.cyto.2015.04.009"},{"issue":"12","key":"2901_CR29","doi-asserted-by":"publisher","first-page":"300060520976477","DOI":"10.1177\/0300060520976477","volume":"48","author":"J-J Zhu","year":"2020","unstructured":"Zhu J-J, Shan N-N (2020) Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia. J Int Med Res 48(12):300060520976477","journal-title":"J Int Med Res"},{"key":"2901_CR30","doi-asserted-by":"crossref","unstructured":"Yu C-R, Yadav MK, Kang M, Jittayasothorn Y, Dong L, Egwuagu CE (2022) Photoreceptor cells Constitutively Express IL-35 and promote ocular Immune Privilege. Int J Mol Sci. ;23(15)","DOI":"10.3390\/ijms23158156"},{"issue":"4","key":"2901_CR31","doi-asserted-by":"publisher","first-page":"e96120","DOI":"10.1371\/journal.pone.0096120","volume":"9","author":"H Terayama","year":"2014","unstructured":"Terayama H, Yoshimoto T, Hirai S, Naito M, Qu N, Hatayama N et al (2014) Contribution of IL-12\/IL-35 common subunit p35 to maintaining the testicular immune privilege. PLoS ONE 9(4):e96120","journal-title":"PLoS ONE"},{"key":"2901_CR32","doi-asserted-by":"publisher","unstructured":"Zhao Z, Chen X, Hao S, Jia R, Wang N, Chen S et al (2017) Increased interleukin-35 expression in tumor-infiltrating lymphocytes correlates with poor prognosis in patients with breast cancer. Cytokine [Internet]. ;89:76\u201381. https:\/\/doi.org\/10.1016\/j.cyto.2016.09.012","DOI":"10.1016\/j.cyto.2016.09.012"},{"issue":"2","key":"2901_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.12639","volume":"181","author":"Z Cai","year":"2015","unstructured":"Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW et al (2015) Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths large (MRL)\/lpr mice. Clin Exp Immunol 181(2):253\u2013266","journal-title":"Clin Exp Immunol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02901-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:29:07Z","timestamp":1719401347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02901-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02901-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent form was taken from all of the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This paper submitted with consent and knowledge of all co-authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}